Overview

A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
Double blind, crossover randomized, multicentric study to compare efficacy and tolerability of concomitant administration of travoprost and brinzolamide versus timolol-dorzolamide fixed combination in patients with glaucoma or ocular hypertension
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Alcon Research
Treatments:
Brinzolamide
Dorzolamide
Ophthalmic Solutions
Timolol
Travoprost
Criteria
Inclusion Criteria:

- Written informed consent

- Diagnosis of bilateral Primary open angle glaucoma or ocular hypertension

- Intra Ocular Pressure above 19 millimeters mercury at screening visit at 8:00 AM

- Stable visual field in last 6 months

- 6 weeks wash out from previous topical medications

Exclusion Criteria:

- Age